ODTX
Odyssey Therapeutics, Inc. • NASDAQ
$17.01 ▼ -5.08% (-0.91)
ODTX
Odyssey Therapeutics, Inc.NASDAQ • $17.01 ▼ -5.08% (-0.91)
Market Cap $491.47 M
52w High $20.30
52w Low $15.35
P/E -3.16
Volume 165.30K
Outstanding Shares 28.89M
Market Cap $491.47 M
52w High $20.30
52w Low $15.35
P/E -3.16
Volume 165.30K
Outstanding Shares 28.89M
About Odyssey Therapeutics, Inc.
https://odysseytx.comOdyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases.
CEO
Gary D. Glick
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Biotechnology
Sector Healthcare
Went public May 8, 2026
Method of going public IPO
Full time employees 100
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0